DexCom, Inc. (BMV:DXCM)

DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of MXN 464.72 billion. The enterprise value is 451.14 billion.

Market Cap	464.72B
Enterprise Value	451.14B

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	390.02M
Shares Outstanding	n/a
Shares Change (YoY)	-1.89%
Shares Change (QoQ)	-0.20%
Owned by Insiders (%)	0.32%
Owned by Institutions (%)	96.17%
Float	387.42M

Valuation Ratios

The trailing PE ratio is 35.15 and the forward PE ratio is 26.93.

PE Ratio	35.15
Forward PE	26.93
PS Ratio	5.61
PB Ratio	9.29
P/TBV Ratio	9.66
P/FCF Ratio	23.86
P/OCF Ratio	17.50
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.43, with an EV/FCF ratio of 23.16.

EV / Earnings	34.13
EV / Sales	5.49
EV / EBITDA	23.43
EV / EBIT	31.88
EV / FCF	23.16

Financial Position

The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.94.

Current Ratio	1.56
Quick Ratio	1.35
Debt / Equity	0.94
Debt / EBITDA	2.43
Debt / FCF	2.43
Interest Coverage	40.93

Financial Efficiency

Return on equity (ROE) is 30.63% and return on invested capital (ROIC) is 9.85%.

Return on Equity (ROE)	30.63%
Return on Assets (ROA)	7.02%
Return on Invested Capital (ROIC)	9.85%
Return on Capital Employed (ROCE)	18.68%
Revenue Per Employee	8.08M
Profits Per Employee	1.29M
Employee Count	10,300
Asset Turnover	0.65
Inventory Turnover	3.06

Taxes

In the past 12 months, DexCom has paid 4.37 billion in taxes.

Income Tax	4.37B
Effective Tax Rate	24.85%

Stock Price Statistics

The stock price has decreased by -21.35% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-21.35%
50-Day Moving Average	1,395.38
200-Day Moving Average	1,964.57
Relative Strength Index (RSI)	43.23
Average Volume (20 Days)	996

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.11

Income Statement

In the last 12 months, DexCom had revenue of MXN 82.83 billion and earned 13.22 billion in profits. Earnings per share was 32.96.

Revenue	82.83B
Gross Profit	48.88B
Operating Income	14.26B
Pretax Income	17.59B
Net Income	13.22B
EBITDA	18.75B
EBIT	14.26B
Earnings Per Share (EPS)	32.96

Balance Sheet

The company has 60.93 billion in cash and 47.24 billion in debt, giving a net cash position of 13.69 billion.

Cash & Cash Equivalents	60.93B
Total Debt	47.24B
Net Cash	13.69B
Net Cash Per Share	n/a
Equity (Book Value)	50.00B
Book Value Per Share	128.21
Working Capital	34.55B

Cash Flow

In the last 12 months, operating cash flow was 26.56 billion and capital expenditures -7.08 billion, giving a free cash flow of 19.48 billion.

Operating Cash Flow	26.56B
Capital Expenditures	-7.08B
Free Cash Flow	19.48B
FCF Per Share	n/a

Margins

Gross margin is 59.01%, with operating and profit margins of 17.22% and 15.96%.

Gross Margin	59.01%
Operating Margin	17.22%
Pretax Margin	21.24%
Profit Margin	15.96%
EBITDA Margin	22.63%
EBIT Margin	17.22%
FCF Margin	23.51%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.89%
Shareholder Yield	1.89%
Earnings Yield	2.84%
FCF Yield	4.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4.

Last Split Date	Jun 13, 2022
Split Type	Forward
Split Ratio	4

Scores

DexCom has an Altman Z-Score of 5.5 and a Piotroski F-Score of 6.

Altman Z-Score	5.5
Piotroski F-Score	6